文献速递临床试验与 GCP基础与转化研究

立体定向脑电图引导射频热凝与 anterior temporal lobectomy 治疗伴海马硬化内侧颞叶癫痫的随机对照试验研究方案

Stereotactic EEG-guided radiofrequency thermocoagulation versus anterior temporal lobectomy for mesial temporal lobe epilepsy with hippocampal sclerosis: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2021-06-29

STARTS 是一项单中心、双臂、随机对照、平行组临床试验,纳入 14 岁以上、耐药至少 2 年且评估为手术候选的典型内侧颞叶癫痫患者,比较立体定向脑电图引导射频热凝与经典前颞叶切除术的安全性和有效性,主要终点为治疗后 1 年认知功能。

要点

  • 比较 SEEG 引导 RF-TC 与经典 ATL 对 mTLE 伴海马硬化的认知功能影响。
  • 主要终点为治疗后 1 年认知功能,次要终点包括癫痫发作结局与视野异常。
  • 该试验为首个比较两种治疗认知结局与治疗结果的随机对照试验。

核心结论

  • SEEG 引导 RF-TC 的癫痫发作结局仍存争议,但可能有利于认知和视野保护。
  • 该试验旨在为 mTLE 伴海马硬化的治疗提供更高级别临床证据。

研究设计与样本

  • STARTS 为单中心、双臂、随机对照、平行组临床试验。
  • 纳入 14 岁以上、耐药至少 2 年、经详细评估确定为手术候选的典型 mTLE 患者。

关键数值与推荐

  • 主要结局指标为治疗后 1 年随访时的认知功能。
  • 次要结局包括癫痫发作结局、术后视野异常、生活质量、辅助结局和不良事件,均在 1 年随访时评估。

临床怎么用

  • 该试验结果可能为 mTLE 伴海马硬化患者选择 SEEG 引导 RF-TC 或经典 ATL 提供认知功能与安全性方面的证据。

局限性

  • 原文未报告研究结果,尚无法评估两种治疗的实际差异。
  • 试验为单中心设计,外部推广性可能受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In this report, we aim to describe the design for the randomised controlled trial of Stereotactic electroencephalogram (EEG)-guided Radiofrequency Thermocoagulation versus Anterior Temporal Lobectomy for Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (STARTS). Mesial temporal lobe epilepsy (mTLE) is a classical subtype of temporal lobe epilepsy that often requires surgical intervention. Although anterior temporal lobectomy (ATL) remains the most popular treatment for mTLE, accumulating evidence has indicated that ATL can cause tetartanopia and memory impairments. Stereotactic EEG (SEEG)-guided radiofrequency thermocoagulation (RF-TC) is a non-invasive alternative associated with lower seizure freedom but greater preservation of neurological function. In the present study, we aim to compare the safety and efficacy of SEEG-guided RF-TC and classical ATL in the treatment of mTLE. METHODS AND ANALYSIS: STARTS is a single-centre, two-arm, randomised controlled, parallel-group clinical trial. The study includes patients with typical mTLE over the age of 14 who have drug-resistant seizures for at least 2 years and have been determined via detailed evaluation to be surgical candidates prior to randomisation. The primary outcome measure is the cognitive function at the 1-year follow-up after treatment. Seizure outcomes, visual field abnormalities after surgery, quality of life, ancillary outcomes, and adverse events will also be evaluated at 1-year follow-up as secondary outcomes. DISCUSSION: SEEG-guided RF-TC for mTLE remains a controversial seizure outcome but has the advantage for cognitive and visual field protection. This is the first RCT studying cognitive outcomes and treatment results between SEEG-guided RF-TC and standard ATL for mTLE with hippocampal sclerosis. This study may provide higher levels of clinical evidence for the treatment of mTLE. TRIAL REGISTRATION: ClinicalTrials.gov NCT03941613 . Registered on May 8, 2019. The STARTS protocol has been registered on the US National Institutes of Health. The status of the STARTS was recruiting and the estimated study completion date was December 31, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang YH, Chen SC, Wei PH, et al. Stereotactic EEG-guided radiofrequency thermocoagulation versus anterior temporal lobectomy for mesial temporal lobe epilepsy with hippocampal sclerosis: study protocol for a randomised controlled trial. Trials. 2021. PMID: 34187524. doi:10.1186/s13063-021-05378-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。